Personalized Medicine and Patent Eligibility under 35 U.S.C. § 101
By EsqSocial Corporation 25/04/14
Double-digit growth is predicted for the molecular diagnostic market in the next several years, driven in part by an increased demand for personalized medicine—medical decisions and therapeutic products tailored to address the precise needs of each...
By: Robins, Kaplan, Miller & Ciresi L.L.P.